Eliem Therapeutics Inc (NASDAQ: ELYM) Stock Information | RedChip

Eliem Therapeutics Inc (NASDAQ: ELYM) Listen to this Section


$6.09
N/A ( 0% ) 124.0K

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Its main drug candidate is ETX-155 for major depressive disorder (MDD) and focal onset seizures (FOS).

Market Data


Open


$6.09

Previous close


$6.09

Volume


124.0K

Market cap


$412.42M

Day range


$5.93 - $6.26

52 week range


$2.35 - $11.55

Insider Ownership Transactions

Total Amount Purchased: -762,185.00 | $ -4,641,706.65

Date Type Amount Purchased Purchaser
2024-06-28 Sale -10000.00 Rosenberg Adam Joseph
2024-06-28 Sale -10000.00 Dunn Judith
2024-06-28 Sale -10000.00 Tate Simon
2024-06-28 Sale -10000.00 Ratcliffe Liam
2024-06-27 Sale -550000.00 Brennan Aoife
2024-06-27 Sale -103907.00 Thomas Stephen Basil
2024-06-21 Sale -5000.00 Pimblett Emily
2024-04-08 Sale -17847.00 Morisset Valerie
2024-03-20 Sale -40000.00 Pimblett Emily
2024-03-04 Sale -5431.00 Morisset Valerie

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
3 Insider transactions 2 Jun 27, 2024
3 Insider transactions 2 Jun 27, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.